Article Text

Download PDFPDF
Systematic review
Point-of-care D-dimer tests can contribute to patient management in outpatients with suspected venous thromboembolism, particularly those at low risk
  1. M Tan,
  2. M V Huisman
  1. Department of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
  1. Correspondence to M V Huisman
    Department of General Internal Medicine - Endocrinology, Section of Vascular Medicine, Leiden University Medical Center, PO Box 9600, 2300RC Leiden, Leiden, The Netherlands; m.v.huisman{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text

Several studies have assessed the accuracy of D-dimer testing in the diagnostic process for venous thromboembolism (VTE). A meta-analysis of the conventional D-dimer tests showed high sensitivities for enzymelinked fluorescent assay, microplate ELISA and latex quantitative assays, at the cost of lower specificity.1 These tests can therefore reliably exclude a VTE, but at the expense of more testing. In addition, a low pretest probability combined with a negative D-dimer test can safely exclude a VTE.2 Recently, newer point-of-care (POC) D-dimer tests have become available. Among the advantages of these tests …

View Full Text


  • Competing interests None.